Caffeine Completed Phase 1 Trials for Alzheimer's Disease (AD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00726726Drug Interaction Study With a Potential Alzheimer's Disease Compound